Increasing importance of dry eye syndrome and the ideal artificial tear: consensus views from a roundtable discussion

References

• Dogru M, Tsubota K. New insights into the diagnosis and treatment of dry eye. Ocul Surface 2004;2:59–75
   PubMedGoogle Scholar
• Smith G. Pathology of the tear film. In: The tear film: structure, function and clinical examination, chapter 5. Oxford: Butterworth-Heinemann; 2002
   Google Scholar
• Lemp MA. Report of the National Eye Institute/Industry Workshop on clinical trials in dry eyes. CLAO J 1995;21: 221–32
   PubMedGoogle Scholar
• American Academy of Ophthalmology. Preferred practice pattern®. Dry eye syndrome, 2003. Available from http://www.aao.org/aao/education/library/ppp/upload/Dry-Eye-Syndrome_.pdf [accessed 16 August 2006]
   Google Scholar
• Department of Health. PRODIGY guidance: dry eye syndrome. Crown Copyright, Department of Health, 2005. Available from http://www.prodigy.nhs.uk/dry_eye_syndrome [accessed 16 August 2006]
   Google Scholar
• Nelson JD, Helms H, Fiscella R, et al. A new look at dry eye disease and its treatment. Adv Ther 2000;17:84–93
   PubMed Web of Science ®Google Scholar
• Mertzanis P, Abetz L, Rajagopalan K, et al. The relative burden of dry eye in patients’ lives: comparisons to a U.S. normative sample. Invest Ophthalmol Vis Sci 2005;46:46–50
   PubMed Web of Science ®Google Scholar
• Schein OD, Munoz B, Tielsch JM, et al. Prevalence of dry eye among the elderly. Am J Ophthalmol 1997;124:723–8
   PubMed Web of Science ®Google Scholar
• Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003;136:318–26
   PubMed Web of Science ®Google Scholar
• Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000;118:1264–8
   PubMed Web of Science ®Google Scholar
• The Schepens Eye Research Institute. Dry eye fact sheet, 2005. Available from http://www.theschepens.org/dry_eye_fact_sheet.htm [accessed 16 August 2006]
   Google Scholar
• Brewitt H, Sistani F. Dry eye disease: the scale of the problem. Surv Ophthalmol 2001;45(Suppl 2):S199–S202
   PubMedGoogle Scholar
• Dogru M, Stern ME, Smith JA, et al. Changing trends in the definition and diagnosis of dry eyes. Am J Ophthalmol 2005;140:507–8
   PubMed Web of Science ®Google Scholar
• Pflugfelder SC, Tseng SCG, Sanabria O, et al. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea 1998;17:38–56
   PubMed Web of Science ®Google Scholar
• Asbell P. Artificial tears: past, present, and future. Presented at Proceedings of the 5th International Symposium on Ocular Pharmacology and Therapeutics – ISOPT. Monte Carlo, Monaco. Italy: Medimond, 2004
   Google Scholar
• Schaumberg DA, Sullivan DA, Dana MR. Epidemiology of dry eye syndrome. Adv Exp Med Biol 2002;506:989–98
   PubMed Web of Science ®Google Scholar
• Montés-Micó R, Cáliz A, Alió JL. Changes in ocular aberrations after instillation of artificial tears in dry-eye patients. J Cataract Refract Surg 2004;30:1649–52
   PubMed Web of Science ®Google Scholar
• Chiou AG, Florakis GJ, Kazim M. Management of conjunctival cicatrizing diseases and severe ocular surface dysfunction. Surv Ophthalmol 1998;43:19–46
   Google Scholar
• Allergan. 2001 Annual Report. Irvine, Calif: Allergan, Inc., 2001.
   Google Scholar
• Pflugfelder SC, Solomon A, Dursun D, Li D-Q. Dry eye and delayed tear clearance: ‘a call to arms’. Adv Exp Med Biol 2002;506:739–43
   Google Scholar
• Göbbels M, Spitznas M. Corneal epithelial permeability of dry eyes before and after treatment with artificial tears. Ophthalmology 1992;99:873–8
   Google Scholar
• Sall KN, Cohen SM, Christensen MT. Efficacy and compatibility of an HP-Guar based lubricant eye drop when used as supportive therapy with a cyclosporine-based ophthalmic emulsion. 2020/B789. Presented at Association for Research in Vision and Ophthalmology annual meeting, Fort Lauderdale, Florida, May 1–5, 2005
   Google Scholar
• Albietz JM. Dry eye: an update on clinical diagnosis, management and promising new treatments. Clin Exp Optom 2001;84:4–18
   PubMedGoogle Scholar
• Begley CG, Chalmers RL, Abetz L, et al. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci 2003;44:4753–61
   PubMed Web of Science ®Google Scholar
• Toda I, Fujishima H, Tsubota K. Ocular fatigue is the major symptom of dry eye. Acta Ophthalmol (Copenh) 1993;71: 347–52
   PubMed Web of Science ®Google Scholar
• Begley CG, Chalmers RL, Mitchell GL, et al. Characterization of ocular surface symptoms from optometric practices in North America. Cornea 2001;20:610–8
   PubMed Web of Science ®Google Scholar
• Schiffman RM, Walt JG, Jacobsen G, et al. Utility assessment among patients with dry eye disease. Ophthalmology 2003;110:1412–9
   PubMed Web of Science ®Google Scholar
• Huang F-C, Tseng S-H, Shih M-H, Chen FK. Effect of artificial tears on corneal surface regularity, contrast sensitivity, and glare disability in dry eyes. Ophthalmology 2002;109:1934–40
   Google Scholar
• Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea 2004;23:762–70
   Google Scholar
• Farris RL. The diagnosis and management of the dry eye. J Ophthalmic Nurs Technol 1997;16:164–74
   PubMedGoogle Scholar
• Adatia FA, Michaeli-Cohen A, Naor J, et al. Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sjögren’s syndrome. Can J Ophthalmol 2004;39:767–71
   PubMed Web of Science ®Google Scholar
• Korb DR, Herman JP, Greiner JV, et al. Lid wiper epitheliopathy and dry eye symptoms. Eye Contact Lens 2005;31:2–8
   PubMedGoogle Scholar
• Goto T, Zheng X, Klyce SD, et al. A new method for tear film stability analysis using videokeratography. Am J Ophthalmol 2003;135:607–12
   PubMed Web of Science ®Google Scholar
• Nichols KK, Nichols JJ, Zadnik K. Frequency of dry eye diagnostic test procedures used in various modes of ophthalmic practice. Cornea 2000;19:477–82
   Google Scholar
• Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and dry eye syndrome. J Am Med Assoc 2001;286:2114–9
   PubMed Web of Science ®Google Scholar
• Krenzer KL, Dana MR, Ullman MD, et al. Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab 2000;85:4874–82
   PubMed Web of Science ®Google Scholar
• Lemp MA. The 1998 Castroviejo lecture. New strategies in the treatment of dry-eye states. Cornea 1999;18:625–32
   Google Scholar
• Stern ME, Beuerman RW, Fox RI, et al. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 1998;17:584–9
   PubMed Web of Science ®Google Scholar
• Gipson IK, Argüeso P. Role of mucins in the function of the corneal and conjunctival epithelia. Int Rev Cytol 2003;231:1–49
   PubMed Web of Science ®Google Scholar
• Argüeso P, Gipson IK. Epithelial mucins of the ocular surface: structure, biosynthesis and function. Exp Eye Res 2001;73: 281–9
   Google Scholar
• Farris RL. Tear osmolarity – a new gold standard? Adv Exp Med Biol 1994;350:495–503
   PubMedGoogle Scholar
• Gilbard JP, Farris RL. Tear osmolarity and ocular surface disease in keratoconjunctivitis sicca. Arch Ophthalmol 1979;97: 1642–6
   PubMed Web of Science ®Google Scholar
• Gilbard JP, Rossi SR, Heyda KG. Tear film and ocular surface changes after closure of the meibomian gland orifices in the rabbit. Ophthalmology 1989;96:1180–6
   Google Scholar
• Ren H, Wilson G. The effect of a shear force on the cell shedding rate of the corneal epithelium. Acta Ophthalmol Scand 1997;75:383–7
   PubMedGoogle Scholar
• Luo L, Li D-Q, Corrales RM, Pflugfelder SC. Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens 2005;31:186–93
   Google Scholar
• Li D-Q, Luo L, Chen Z, et al. JNK and ERK MAP kinases mediate induction of IL-1β, TNF-α and IL-8 following hyper-osmolar stress in human limbal epithelial cells. Exp Eye Res 2006;82: 588–96
   Google Scholar
• Stern ME, Pflugfelder SC. Inflammation in dry eye. Ocul Surface 2004;2:124–30
   PubMedGoogle Scholar
• Asbell PA, Potapova N. Effects of topical antiglaucoma medications on the ocular surface. Ocul Surface 2005;3:27–40
   PubMed Web of Science ®Google Scholar
• Rieger G. The importance of the precorneal tear film for the quality of optical imaging. Br J Ophthalmol 1992;76:157–8
   PubMed Web of Science ®Google Scholar
• Furrer P, Mayer JM, Gurny R. Ocular tolerance of preservatives and alternatives. Eur J Pharm Biopharm 2002;53:263–80
   PubMed Web of Science ®Google Scholar
• Ridder III WH, Lamotte JO, Ngo L, Fermin J. Short-term effects of artificial tears on visual performance in normal subjects. Optom Vis Sci 2005;82:370–7
   PubMed Web of Science ®Google Scholar
• Durand-Cavagna G, Delort P, Duprat P, et al. Corneal toxicity studies in rabbits and dogs with hydroxyethyl cellulose and benzalkonium chloride. Fundam Appl Toxicol 1989;13: 500–8
   Google Scholar
• US Food and Drug Administration. Code of federal regulations, title 21, 2004. Available from http://www.accessdata.fda. gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=50 [accessed 16 August 2006]
   Google Scholar
• Rieger G. Lipid-containing eye drops: a step closer to natural tears. Ophthalmologica 1990;201:206–12
   PubMed Web of Science ®Google Scholar
• Bachman WG, Wilson G. Essential ions for maintenance of the corneal epithelial surface. Invest Ophthalmol Vis Sci 1985;26:1484–8
   PubMed Web of Science ®Google Scholar
• Lemp MA, Goldberg M, Roddy MR. The effect of tear substitutes on tear film break-up time. Invest Ophthalmol 1975;14:255–8
   Google Scholar
• Tiffany JM. The viscosity of human tears. Int Ophthalmol 1991;15:371–6
   PubMed Web of Science ®Google Scholar
• Snibson GR, Greaves JL, Soper NDW, et al. Precorneal residence times of sodium hyaluronate solutions studied by quantitative gamma scintigraphy. Eye 1990;4:594–602
   PubMed Web of Science ®Google Scholar
• Chowdary KPR, Rao YS. Mucoadhesive microspheres for controlled drug delivery. Biol Pharm Bull 2004;27:1717–24
   PubMed Web of Science ®Google Scholar
• Jones MB, Please CP, McElwain DLS, et al. Dynamics of tear film deposition and draining. Math Med Biol 2005;22:265–88
   PubMed Web of Science ®Google Scholar
• Noecker R. Effects of common ophthalmic preservatives on ocular health. Adv Ther 2001;18:205–15
   PubMed Web of Science ®Google Scholar
• Berdy GJ, Abelson MB, Smith LM, George MA. Preservative-free artificial tear preparations. Assessment of corneal epithelial toxic effects. Arch Ophthalmol 1992;110:528–32
   Google Scholar
• Albietz JM, Bruce AS. The conjunctival epithelium in dry eye subtypes: effect of preserved and non-preserved topical treatments. Curr Eye Res 2001;22:8–18
   PubMed Web of Science ®Google Scholar
• Burstein NL. The effects of topical drugs and preservatives on the tears and corneal epithelium in dry eye. Trans Ophthalmol Soc UK 1985;104:402–9
   PubMedGoogle Scholar
• López Bernal D, Ubels JL. Quantitative evaluation of the corneal epithelial barrier: effect of artificial tears and preservatives. Curr Eye Res 1991;10:645–56
   Google Scholar
• Noecker R. Ophthalmic preservatives: considerations for long-term use in patients with dry eye or glaucoma. Review of Ophthalmology, 2001. Available from http://www.revophth. com/2001/june/cme0601.htm [accessed 16 August 2006]
   Google Scholar
• GenTeal® Artificial Tears Product Information. Novartis Ophthalmics Canada, 2005. Available from http://www.novartisophthalmics.ca/e/products/genteal.shtml [accessed 16 August 2006]
   Google Scholar
• Refresh Tears® Product Information. Irvine, Calif: Allergan, Inc., 2005. Available from http://www.allergan.com/site/products/practitioners/?id=refresh_tears&largeText=no [accessed 16 August 2006]
   Google Scholar
• Paugh JR, Brennan NA, Efron N. Ocular response to hydrogen peroxide. Am J Optom Physiol Optics 1988;65:91–8
   PubMedGoogle Scholar
• American Optometric Association. Care of the patient with ocular surface disorders. St. Louis (MO): American Optometric Association; 2003. Available from http://www.aoa.org/documents/CPG-10.pdf [accessed 16 August 2006]
   Google Scholar
• Manni G, Centofanti M, Oddone F, et al. Interleukin-1β tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers. Am J Ophthalmol 2005;139:72–7
   PubMed Web of Science ®Google Scholar
• Baudouin C, de Lunardo C. Short term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers. Br J Ophthalmol 1998;82:39–42
   PubMed Web of Science ®Google Scholar
• US Government Printing Office. Title 21: food and drugs: 200.50 ophthalmic preparations and dispensers. Electronic Code of Federal Regulations (e-CFR), 1982. Available from http://ecfr.gpoaccess.gov [accessed 16 August 2006]
   Google Scholar